IGC Pharma reports promising Alzheimer’s treatment results By Investing.com
[ad_1] © Reuters. POTOMAC, Md. – IGC Pharma Inc. (NYSE American: IGC) has shared interim results from its Phase 2 clinical trial of IGC-AD1, which...
Acumen’s Alzheimer’s drug passes initial safety test By Reuters
[ad_1] © Reuters. FILE PHOTO: Dr. Seth Gale points out evidence of Alzheimer’s disease on PET scans at the Center for Alzheimer Research and Treatment...
US FDA grants standard approval of Eisai/Biogen Alzheimer’s drug By Reuters
[ad_1] © Reuters. FILE PHOTO: The Alzheimer’s drug LEQEMBI is seen in this undated handout image obtained by Reuters on January 20, 2023. Eisai/Handout via...
Alzheimer’s drugmakers seek accelerated FDA review despite U.S. coverage decision By Reuters
[ad_1] © Reuters. FILE PHOTO: The logo of Eisai Co Ltd is displayed at the company headquarters in Tokyo, Japan, March 8, 2018. REUTERS/Issei Kato...
Alzheimer’s patient groups pressure U.S. to pay for Biogen drug By Reuters
[ad_1] © Reuters. An advertisement aimed at loosening proposed restrictions on new Alzheimer’s treatments is seen in this undated handout image. UsAgainstAlzheimer?s Action/Handout via REUTERS...